LRCX - Lam Research Corporation
NASDAQ
->
Technology
->
Semiconductor Equipment & Materials
Fremont,
United States
Type: Equity
LRCX price evolution
LRCX
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 25 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5623.29 | $5126.15 | $5587.37 | |
| Short term investments | $14.72 | $30.56 | $37.64 | |
| Net receivables | $2707.46 | $2810.95 | $2823.38 | |
| Inventory | $4429.91 | $4747.78 | $4816.19 | |
| Total current assets | $13054.61 | $12993.56 | $13228.41 | |
| Long term investments | ||||
| Property, plant & equipment | $2147.48 | $2110.51 | $1856.67 | |
| Goodwill & intangible assets | $1777.59 | $1784 | $1790.94 | |
| Total noncurrent assets | $5729.24 | $5544.9 | $5553.23 | |
| Total investments | $14.72 | $30.56 | $37.64 | |
| Total assets | $18783.85 | $18538.46 | $18781.64 | |
| Current liabilities | ||||
| Accounts payable | $499.7 | $528.16 | $470.7 | |
| Deferred revenue | $1792.95 | $1595.1 | $1695.22 | |
| Short long term debt | $3.78 | $3.86 | $8.36 | |
| Total current liabilities | $4272.38 | $4247.18 | $4184.92 | |
| Long term debt | $4980.01 | $4980.46 | $5003.18 | |
| Total noncurrent liabilities | $6288.99 | $6243.95 | $6386.55 | |
| Total debt | $4983.78 | $4984.32 | $5011.54 | |
| Total liabilities | $10561.37 | $10491.13 | $10571.47 | |
| Shareholders' equity | ||||
| Retained earnings | $23347.15 | $22655.39 | $22032.1 | |
| Other shareholder equity | -$117.69 | -$121.35 | $8210.17 | |
| Total shareholder equity | $8222.48 | $8047.33 | $8210.17 | |
| (in millions $) | 25 Jul 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5587.37 | $3773.53 | $4670.75 | $5169.08 |
| Short term investments | $37.64 | $135.73 | $1310.87 | $1795.08 |
| Net receivables | $2823.38 | $4313.82 | $3026.43 | $2097.1 |
| Inventory | $4816.19 | $3966.29 | $2689.29 | $1900.02 |
| Total current assets | $13228.41 | $12285.24 | $11652.39 | $10853.53 |
| Long term investments | ||||
| Property, plant & equipment | $1856.67 | $1647.59 | $1303.48 | $1071.5 |
| Goodwill & intangible assets | $1790.94 | $1616.96 | $1622.5 | $1652.97 |
| Total noncurrent assets | $5553.23 | $4910.4 | $4239.77 | $3705.51 |
| Total investments | $37.64 | $135.73 | $1310.87 | $1795.08 |
| Total assets | $18781.64 | $17195.63 | $15892.15 | $14559.05 |
| Current liabilities | ||||
| Accounts payable | $470.7 | $1011.21 | $829.71 | $592.39 |
| Deferred revenue | $1695.22 | $1571.9 | $967.33 | $457.52 |
| Short long term debt | $8.36 | $7.38 | $11.35 | $839.88 |
| Total current liabilities | $4184.92 | $4564.76 | $3527.87 | $3162.44 |
| Long term debt | $5003.18 | $4998.45 | $4990.33 | $4970.85 |
| Total noncurrent liabilities | $6386.55 | $6352.51 | $6337.1 | $6213.12 |
| Total debt | $5011.54 | $5005.83 | $5001.68 | $5810.73 |
| Total liabilities | $10571.47 | $10917.27 | $9864.96 | $9375.56 |
| Shareholders' equity | ||||
| Retained earnings | $22032.1 | $18454.72 | $14684.91 | $11520.59 |
| Other shareholder equity | $8210.17 | $6278.37 | -$64.13 | -$94.21 |
| Total shareholder equity | $8210.17 | $6278.37 | $6027.19 | $5172.49 |
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 25 Jul 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3758.26 | $3482.06 | $3207.26 | |
| Cost of revenue | $2000.8 | $1827.36 | ||
| Gross Profit | $1757.45 | $1654.7 | $1457.83 | |
| Operating activities | ||||
| Research & development | $469.71 | $422.63 | ||
| Selling, general & administrative | $228.84 | $207.02 | ||
| Total operating expenses | $700.24 | $631.67 | $600.38 | |
| Operating income | $1057.21 | $1023.03 | ||
| Income from continuing operations | ||||
| EBIT | $1087.05 | $1025.63 | ||
| Income tax expense | $132.78 | $138.23 | $61.08 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $954.27 | $887.4 | $802.54 | |
| Income (for common shares) | $954.27 | $887.4 | ||
| (in millions $) | 25 Jul 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $17428.52 | $14626.15 | $10044.74 | |
| Cost of revenue | $7820.84 | $5436.04 | ||
| Gross Profit | $7870.74 | $6805.31 | $4608.69 | |
| Operating activities | ||||
| Research & development | $1493.41 | $1252.41 | ||
| Selling, general & administrative | $829.88 | $682.48 | ||
| Total operating expenses | $2552.93 | $2323.28 | $1934.89 | |
| Operating income | $4482.02 | $2673.8 | ||
| Income from continuing operations | ||||
| EBIT | $4370.8 | $2574.98 | ||
| Income tax expense | $598.28 | $462.35 | $323.23 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $4510.93 | $3908.46 | $2251.75 | |
| Income (for common shares) | $3908.46 | $2251.75 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 25 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $954.27 | $887.4 | $814.01 | |
| Operating activities | ||||
| Depreciation | $90.94 | $90.48 | $91.66 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $69.9 | $67.21 | $73.91 | |
| Total cash flows from operations | $1453.84 | $951.16 | $1726.44 | |
| Investing activities | ||||
| Capital expenditures | -$115.28 | -$76.99 | -$119.46 | |
| Investments | $15.84 | $7.28 | $39.41 | |
| Total cash flows from investing | -$101.96 | -$74.68 | -$534.56 | -$84.33 |
| Financing activities | ||||
| Dividends paid | -$264.41 | -$230.33 | -$907.91 | -$233.98 |
| Sale and purchase of stock | -$590.67 | -$840.42 | -$581.94 | |
| Net borrowings | -$0.99 | -$253.11 | -$2.21 | |
| Total cash flows from financing | -$859.89 | -$1326.01 | -$2830.67 | -$819.53 |
| Effect of exchange rate | $6.72 | -$11.03 | $0.13 | -$2.3 |
| Change in cash and equivalents | $498.71 | -$460.56 | $1813.84 | $820.28 |
| (in millions $) | 25 Jul 2023 | 26 Jul 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $3908.46 | $2251.75 | ||
| Operating activities | ||||
| Depreciation | $307.15 | $268.52 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $220.16 | $189.2 | ||
| Total cash flows from operations | $3588.16 | $2126.45 | ||
| Investing activities | ||||
| Capital expenditures | -$349.1 | -$203.24 | ||
| Investments | $464.52 | -$15 | ||
| Total cash flows from investing | -$534.56 | $612.27 | $73.27 | -$244.08 |
| Financing activities | ||||
| Dividends paid | -$907.91 | -$815.29 | -$726.99 | -$656.84 |
| Sale and purchase of stock | -$2575.82 | -$1276.13 | ||
| Net borrowings | -$862.06 | $1307.11 | ||
| Total cash flows from financing | -$2830.67 | -$4578.94 | -$4166.98 | -$623.93 |
| Effect of exchange rate | $0.13 | -$30.23 | $7.21 | -$2.75 |
| Change in cash and equivalents | $1813.84 | -$897.21 | -$498.33 | $1255.69 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.29 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |